未经授权:在上肢血栓形成研究中,上肢血栓形成后综合征(UE-PTS)的发生通常被用作主要预后参数.然而,目前没有报告标准或经过验证的方法来评估UE-PTS的存在和严重程度。在最近的Delphi研究中,就初步的UE-PTS分数达成共识,结合5种症状,3个标志,并纳入功能性残疾评分。然而,对于纳入哪个功能残疾评分没有达成共识.
UNASSIGNED:当前Delphi共识研究的目的是确定功能性残疾评分的具体类型,以最终确定UE-PTS评分。
UNASSIGNED:这个Delphi项目被设计为使用开放文本问题的三轮研究,7点李克特量表的陈述,和多项选择题。适用于Delphi研究的CRDES建议。在这种情况下,我们在Delphi轮开始前进行了系统评价,以确定文献中可用的功能性残疾评分,并将这些评分提交给专家小组.
UNASSIGNED:47名最初邀请来自多个学科的国际专家中,有35名完成了所有德尔菲回合。在第二轮中,就纳入手臂快速残疾达成共识,肩膀,和手(QuickDASH)在UE-PTS得分,使第三轮过时。
未经授权:达成共识,即QuickDASH应纳入UE-PTS评分中。UE-PTS评分需要在大量上肢血栓患者中进行验证,然后才能用于临床实践和未来的研究。
UNASSIGNED: In upper extremity thrombosis research, the occurrence of upper extremity postthrombotic syndrome (UE-PTS) is commonly used as the main outcome parameter. However, there is currently no reporting standard or a validated method to assess UE-PTS presence and severity. In a recent Delphi study,
consensus was reached on a preliminary UE-PTS score, combining 5 symptoms, 3 signs, and the inclusion of a functional disability score. However, no
consensus was reached on which functional disability score to be included.
UNASSIGNED: The aim of the current Delphi
consensus study was to determine the specific type of functional disability score to finalize UE-PTS score.
UNASSIGNED: This Delphi project was designed as a three-round study using open text questions, statements with 7-point Likert scales, and multiple-choice questions. The CREDES recommendations for Delphi studies were applied. In this context, a systematic review was conducted before the start of the Delphi rounds to identify the available functional disability scores as available in the literature and present these to the expert panel.
UNASSIGNED: Thirty-five of 47 initially invited international experts from multiple disciplines completed all the Delphi rounds. In the second round,
consensus was reached on the incorporation of the quick disabilities of the arm, shoulder, and hand (QuickDASH) in the UE-PTS score, rendering the third round obsolete.
UNASSIGNED: Consensus was reached that the QuickDASH should be incorporated in the UE-PTS score. The UE-PTS score will need to be validated in a large cohort of patients with upper extremity thrombosis before it can be used in clinical practice and future research.